MetLife Investment Management’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $18.3M | Sell |
82,882
-1,361
| -2% | -$376K | 0.08% | 213 |
|
|
2026
Q1 | $24.9M | Sell |
84,243
-2,184
| -3% | -$649K | 0.13% | 125 |
|
|
2025
Q4 | $23.6M | Sell |
86,427
-2,975
| -3% | -$808K | 0.11% | 131 |
|
|
2025
Q3 | $24.2M | Sell |
89,402
-2,407
| -3% | -$655K | 0.12% | 128 |
|
|
2025
Q2 | $25.3M | Sell |
91,809
-1,775
| -2% | -$483K | 0.15% | 104 |
|
|
2025
Q1 | $24.8M | Sell |
93,584
-1,782
| -2% | -$440K | 0.13% | 115 |
|
|
2024
Q4 | $22.1M | Buy |
95,366
+1,744
| +2% | +$401K | 0.12% | 127 |
|
|
2024
Q3 | $20.7M | Sell |
93,622
-2,406
| -3% | -$498K | 0.12% | 135 |
|
|
2024
Q2 | $18.9M | Buy |
96,028
+11,756
| +14% | +$2.43M | 0.11% | 135 |
|
|
2024
Q1 | $18.1M | Sell |
84,272
-3,100
| -4% | -$651K | 0.12% | 128 |
|
|
2023
Q4 | $18.4M | Sell |
87,372
-1,597
| -2% | -$341K | 0.13% | 121 |
|
|
2023
Q3 | $17.8M | Sell |
88,969
-2,321
| -3% | -$461K | 0.14% | 120 |
|
|
2023
Q2 | $16.9M | Sell |
91,290
-1,525
| -2% | -$282K | 0.12% | 130 |
|
|
2023
Q1 | $17.8M | Sell |
92,815
-1,113
| -1% | -$201K | 0.13% | 121 |
|
|
2022
Q4 | $15.8M | Sell |
93,928
-1,466
| -2% | -$255K | 0.12% | 134 |
|
|
2022
Q3 | $16.9M | Sell |
95,394
-1,418
| -1% | -$280K | 0.14% | 117 |
|
|
2022
Q2 | $19.8M | Sell |
96,812
-962
| -1% | -$204K | 0.15% | 109 |
|
|
2022
Q1 | $23.3M | Buy |
97,774
+18,368
| +23% | +$4.31M | 0.15% | 108 |
|
|
2021
Q4 | $18.1M | Sell |
79,406
-1,709
| -2% | -$376K | 0.15% | 113 |
|
|
2021
Q3 | $15.7M | Sell |
81,115
-2,139
| -3% | -$433K | 0.14% | 123 |
|
|
2021
Q2 | $17.7M | Sell |
83,254
-2,297
| -3% | -$485K | 0.16% | 111 |
|
|
2021
Q1 | $17.5M | Sell |
85,551
-1,631
| -2% | -$321K | 0.16% | 112 |
|
|
2020
Q4 | $15.9M | Sell |
87,182
-3,745
| -4% | -$637K | 0.15% | 118 |
|
|
2020
Q3 | $15.2M | Sell |
90,927
-2,856
| -3% | -$481K | 0.17% | 107 |
|
|
2020
Q2 | $15.2M | Buy |
93,783
+1,411
| +2% | +$253K | 0.17% | 110 |
|
|
2020
Q1 | $16M | Sell |
92,372
-2,826
| -3% | -$562K | 0.22% | 85 |
|
|
2019
Q4 | $19.1M | Sell |
95,198
-2,252
| -2% | -$462K | 0.2% | 93 |
|
|
2019
Q3 | $20.6M | Sell |
97,450
-1,221
| -1% | -$255K | 0.23% | 82 |
|
|
2019
Q2 | $19.2M | Sell |
98,671
-3,025
| -3% | -$558K | 0.2% | 88 |
|
|
2019
Q1 | $16.7M | Sell |
101,696
-616
| -0.6% | -$109K | 0.18% | 105 |
|
|
2018
Q4 | $19.2M | Buy |
102,312
+3,233
| +3% | +$597K | 0.23% | 83 |
|
|
2018
Q3 | $16.9M | Sell |
99,079
-1,159
| -1% | -$195K | 0.17% | 109 |
|
|
2018
Q2 | $16.4M | Sell |
100,238
-2,196
| -2% | -$359K | 0.19% | 94 |
|
|
2018
Q1 | $16.6M | Sell |
102,434
-2,855
| -3% | -$454K | 0.2% | 98 |
|
|
2017
Q4 | $15.4M | Buy |
+105,289
| New | +$15M | 0.17% | 112 |
|
Other funds holding CME
MetLife Investment Management's CME Position: Q2 2026 in Review
MetLife Investment Management reduced its CME Group (CME) stake by 1.6% in Q2 2026, selling an estimated $376K and leaving 82,882 shares worth $18.3M. The position accounts for 0.08% of the portfolio, ranked #213.
MetLife Investment Management first reported a position in CME in Q4 2017 and has held it in 35 quarters since. The position peaked at $25.3M in Q2 2025. 1,694 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- MetLife Investment Management held 82,882 shares of CME Group worth $18.3M as of Q2 2026.
- MetLife Investment Management sold 1,361 CME Group shares in Q2 2026, an estimated $376K.
- CME Group made up 0.08% of MetLife Investment Management's portfolio in Q2 2026, its #213 holding.
- MetLife Investment Management first reported a position in CME Group in Q4 2017 and has held it in 35 quarters since.
- MetLife Investment Management's CME Group position peaked at $25.3M in Q2 2025.
- 1,694 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.